Disease management in horses encompasses the strategies and practices employed to prevent, control, and treat diseases affecting equine populations. This field involves understanding the etiology, transmission, and clinical presentation of various equine diseases, as well as implementing biosecurity measures and therapeutic interventions. Common diseases in horses include equine influenza, strangles, and equine herpesvirus. Effective disease management relies on accurate diagnosis, vaccination protocols, and the use of antimicrobials and other treatments. This page compiles peer-reviewed research studies and scholarly articles that explore the methodologies, challenges, and advancements in managing diseases in equine health.
Pecheur M.A number of good anthelmintic drugs are currently available which eliminate gastrointestinal nematodes of equids with over 90% success. This is shown by comparing results of critical tests conducted with 9 anthelmintic agents on ponies using the following dosages: 19 mg/kg for Pyrantel embonate, 10 mg/kg for Oxfendazole, 10 mg/kg for Mebendazole, 5 mg/kg for Albendazole, 40 mg/kg for Dichlorvos, 44 mg/kg for Thiabendazole, 7.5 mg/kg, for Fenbendazole, 20 mg/kg for Cambendazole and 7 mg/kg for Parbendazole. From 6 to 9 ponies were treated with each of these anthelmintic agents. Based on total a...
Baker JR, Ellis CE.Disease processes not directly related to the cause of death recorded in 480 consecutive post mortem examinations of horses performed at the department of pathology, Veterinary Field Station, University of Liverpool, between February 1958 and February 1980 are reported. The alimentary, cardiovascular, respiratory and locomotor systems were those most frequently diseased. The most common specific entities were those associated with endoparasitism and its associated vascular lesions, pneumonia and fractures.
Kuiper R, Franken P.The course run by the disease is described in a horse which showed the symptom complex of colitis X following treatment with oxytetracycline. Disseminated intravascular coagulation was also observed in this horse. The possibility of disseminated intravascular coagulation being part of colitis X is discussed.
Trommershausen-Smith A.Dead or deformed foals produced by purebred parents represent an economic and emotional loss to the horse breeder. To avoid repeating production of such defective foals, the breeder may seek assistance in identifying the possible environmental or genetic causes for such animals. Only a few genetic diseases of the horse have been rigorously defined. Selected rare genetic diseases that prevent reproduction, cause the natural death or necessitate the humane destruction of a foal before it fulfills its intended purpose serve as examples for the definition of genetics of other deleterious diseases ...
Bowling AT.Dead or deformed foals produced by purebred parents represent an economic and emotional loss to the horse breeder. In order to avoid producing such defective foals in the future, the breeder may seek guidance in determining whether their origin is environmental or genetic. Only a few genetic diseases of horses have been rigorously defined. Selected, rare genetic diseases that prevent reproduction, cause the natural death, or necessitate the humane destruction of a foal before it fulfills its intended purpose serve as examples for collecting evidence to define the genetics of other deleterious ...
Wingfield Digby NJ, Simons MA, Stockman MJ.Various type of insurance policies covering the risks against mortality, economic slaughter and loss of use, breeding failures and payment of veterinary fees are discussed. The role of the veterinary surgeon in supplying certificates of health and in relation to claims, including those involving destruction on humane grounds, are considered.
British medical journalSeptember 13, 1980
Volume 281, Issue 6242 699-702 doi: 10.1136/bmj.281.6242.699
English TA, Cooper DK, Cory-Pearce R.The major factors contributing to the recommencement of clinical heart transplantation in the United Kingdom last year were the steadily improving results from Stanford University, the clarification of the diagnosis of brain death, and advances in preserving donor hearts. Twelve men aged 16 to 52 years received heart transplants at Papworth Hospital from January 1979 to July 1980. Six had cardiomyopathies and six ischaemic heart disease. The donors were aged 16 to 35 (mean 21) years. A combination of road and air transport was used to transport the heart to Papworth in seven cases. The total d...
Kamada M, Ando Y, Fukunaga Y, Kumanomido T, Imagawa H, Wada R, Akiyama Y.A primary enzootic of equine Getah virus infection involving 722 of 1,903 racehorses occurred at a training center in Japan between September and November of 1978. Sixty-two viral agents were isolated from the plasma of 209 sick horses which exhibited pyrexia with rectal temperatures ranging from 38.5--40 degrees C, urticarial rash on various portions of the body, and edema of the hind legs. The viruses were antigenically related to the AMM 2021, Haruna, and Sagiyama strains of Getah virus. Infection and disease were produced experimentally in horses when inoculated by the intramuscular or int...
Kono Y, Sentsui H, Ito Y.A virus (Sakai) which had been recovered from an outbreak of disease in horses was found to be a small spherical enveloped RNA virus with a diameter of approximately 70 nm and a buoyant density of 1.22 g per ml. It grew well and produced a cytopathic effect in a variety of cell cultures; it was sensitive to organic solvents, heat and low pH. It agglutinated goose erythrocytes in a 0.35 M sodium chloride solution at an optimum pH of 6.2 and was antigenically identical or closely related to Getah virus, a member of the alphavirus subgroup of the Togaviridae.
Drudge JH, Lyons ET, Tolliver SC.The basic-dose confirmation tests of tioxidazole for removal of susceptible populations of gastrointestinal parasites of the horse were made in 10 naturally infected horses, using the critical test method (experiment A). A single dose of toxidazole, given at the rate of 11 mg/kg of body weight, was administered to 5 horses by stomach tube and to 5 horses by mixing the drug with the daily grain ration. In the 5 horses given the drug by stomach tube, aggregate average removals were 90% or more for 5 horses infected with Stronglyus vulgaris, 5 infected with S edentatus, 5 infected with small stro...
Archer M.The pasture needs for horses as compared to those for farm livestock are reviewed. The differing preferences of various types of grasses and other plants, and the patterns of grazing seen on"horse-sick" pastures, are discussed. Suggestions for practical management include frequent collection and removal of droppings, the use of grazing by cattle, adequate rest from horses and the application of cattle manure. Methods for controlling weeds and renovating horse-sick paddocks are discussed and compared to ploughing up. Finally, the place of fertilisers is considered for use on pastures for horses...
Yoxall AT.This paper is an introduction to a series of commissioned articles on therapeutic medicine to be published in Equine Veterinary Journal under differing authorship, during the next 2 years. It presents an account of fundamental concepts common to the use of all drugs and introduces some pharmacokinetic principles to which reference will be made in later articles.
Akinboade OA, Awani O, Best O, Cole T.Summary Twelve (12) heavy horses of the Shire breed imported into Nigeria in 1974 died within two months after importation. This was because of inclement weather and non-availability of AHS vaccine.
Stanley SD, Moffitt K, Wiebe V.Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
Kaji Y, Taniyama H, Matsukawa K, Okada H, Tsunoda S, Tagami M, Akita H.Nodular hepatic lesions caused by larval Echinococcus multilocularis were found in a four-year-old female thoroughbred race horse born and raised in Hokkaido. Before detection of the infection, the infected animal was transported around Honshu for racing. The present disclosure of hydatidosis in a race horse raises concern over the potential danger of spreading the infection throughout Japan by horses possibly infected in Hokkaido.
Haynes KF, McLaughlin J, Stamper S, Rucker C, Webster FX, Czokajlo D, Kirsch P.The discovery that the eastern tent caterpillar Malacosoma americanum (F.) causes mare reproductive loss syndrome (MRLS), and thus has the potential to continue to result in major economic losses to the equine industry of Kentucky, has resulted in an intensive effort to identify practical means to monitor and control this defoliator, including these experiments to optimize a sex pheromone trap for this pest. A pheromone-baited delta trap with a large opening, such as InterceptST Delta, was more effective than other tested traps. Orange delta traps caught more moths than other tested colors. ET...
Hara Y, Nakajima T, Akamatsu M, Yahiro M, Kagawa S, Petry S, Matsuda M, Moore JE.Contagious equine metritis is a bacterial infectious disease of horses caused by Taylorella equigenitalis, a Gram-negative eubacterium. The disease has been described in several continents, including Europe, North America and Asia. A novel molecular method was developed to detect clustered regularly interspaced short palindromic repeats (CRISPRs), which were separated by non-repetitive unique spacer regions (NRUSRs) of similar length, in the Taylorella equigenitalis EQ59 strain using a primer pair, f-/r-TeCRISPR-ladder, by PCR amplification. In total, 31 Taylorella isolates (17 T. equigenitali...
Equine infectious anaemia in Europe Equine herpesvirus in the UK Summary of surveillance testing, July to September 2012 These are among matters discussed in the quarterly equine disease surveillance report for July to September 2012, prepared by Defra, the Animal Health Trust and the British Equine Veterinary Association.